EN3835 for the Treatment of Edematous Fibrosclerotic Panniculopathy (Commonly Known as Cellulite)
Phase of Trial: Phase II
Latest Information Update: 09 May 2017
At a glance
- Drugs Collagenase clostridium histolyticum (Primary)
- Indications Cellulite
- Focus Therapeutic Use
- Sponsors Auxilium Pharmaceuticals; Endo Pharmaceuticals
- 15 Mar 2017 According to a BioSpecifics Technologies Corporation media release, full data expected in the second half of 2017.
- 17 Nov 2016 Results published in the Endo International Media Release.
- 17 Nov 2016 According to a BioSpecifics Technologies Corporation media release, status changed from active, no longer recruiting to completed.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History